alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.b

I, Marc N. Teal, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Boston Capital Tax Credit Fund Limited Partnership;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



1. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
2. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
3. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and





1. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



1. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
2. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



|Date:  August 20, 2007 | /s/ Marc N. Teal                         
|---------------------- | -----------------------------------------
|                       | Marc N. Teal,
Principal Financial Officer
II 

116TH CONGRESS 

1ST SESSION S. 784 

To amend the Elementary and Secondary Education Act of 1965 to expand 

the military student identifier program to cover students with a parent 

who serves in the reserve component of the Armed Forces. 

IN THE SENATE OF THE UNITED STATES 

MARCH 13, 2019 

Ms. KLOBUCHAR (for herself and Ms. COLLINS) introduced the following bill; 

which was read twice and referred to the Committee on Health, Education, Labor, and Pensions 

A BILL 

To amend the Elementary and Secondary Education Act 

of 1965 to expand the military student identifier program to cover students with a parent who serves in 

the reserve component of the Armed Forces. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Supporting Children 

5 of the National Guard and Reserve Act’’. 

6 SEC. 2. ANNUAL STATE REPORT CARD. 

7 Section 1111(h)(1)(C)(ii) of the Elementary and Sec8 ondary Education Act of 1965 (20 U.S.C. 


kjohnson on DSK79L0C42 with BILLS
2 

•S 784 IS

1 6311(h)(1)(C)(ii)) is amended by striking ‘‘on active duty 

2 (as defined in section 101(d)(5) of such title)’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 62 Introduced in Senate (IS)]

<DOC>

116th CONGRESS
  1st Session
                                 S. 62

To amend title XVIII of the Social Security Act to allow the Secretary 
of Health and Human Services to negotiate fair prescription drug prices 
                 under part D of the Medicare program.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 9, 2019

 Ms. Klobuchar (for herself, Ms. Baldwin, Mr. Bennet, Mr. Blumenthal, 
Mr. Booker, Mr. Brown, Ms. Cantwell, Mr. Cardin, Ms. Cortez Masto, Ms. 
 Duckworth, Mrs. Gillibrand, Ms. Harris, Ms. Hassan, Mr. Heinrich, Ms. 
 Hirono, Mr. Kaine, Mr. King, Mr. Leahy, Mr. Manchin, Mr. Merkley, Mr. 
 Murphy, Mrs. Murray, Mr. Reed, Mr. Schumer, Mrs. Shaheen, Ms. Smith, 
 Ms. Stabenow, Mr. Udall, Mr. Van Hollen, Ms. Warren, Mr. Whitehouse, 
 Mr. Warner, Mr. Wyden, and Mr. Peters) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To amend title XVIII of the Social Security Act to allow the Secretary 
of Health and Human Services to negotiate fair prescription drug prices 
                 under part D of the Medicare program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Empowering Medicare Seniors to 
Negotiate Drug Prices Act of 2019''.

SEC. 2. AUTHORITY TO NEGOTIATE FAIR PRICES FOR MEDICARE PRESCRIPTION 
              DRUGS.

    (a) In General.--Section 1860D-11 of the Social Security Act (42 
U.S.C. 1395w-111) is amended by striking subsection (i).
    (b) Effective Date.--The amendment made by this section shall take 
effect on the date of the enactment of this Act.
                                 <all>
```
Exhibit 99.2



CERTIFICATION PURSUANT TO

18 U.S.C. § 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



The undersigned Chief Financial Officer of Service Bancorp,
Inc. (the Company) hereby certifies that the Companys quarterly report on Form 10-QSB for the quarterly period ended March 31, 2003 (the Report), as filed with the Securities and Exchange Commission on the date hereof,
fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.





|                   |  |  |  | 
|------------------ |  |  |  | 
|                  
|Date: May 13, 2003 |  |  |  | 
|                   |  |  |  |
# C_2013344EN.01000902.xml

| 23.11.2013 | EN | Official Journal of the European Union | C 344/9 |
| --- | --- | --- | --- |

23.11.2013

EN

Official Journal of the European Union

C 344/9

---

Judgment of the Court (Fifth Chamber) of 19 September 2013 (request for a preliminary ruling from the Symvoulio tis Epikrateias — Greece) — Panellinios Sindesmos Viomikhanion Metapiisis Kapnou v Ipourgos Ikonomias kai Ikonomikon, Ipourgos Agrotikis Anaptixis kai Trofimon

(Case C-373/11) (1)

1

(Request for a preliminary ruling - Assessment of validity - Common Agricultural Policy - Regulation (EC) No 1782/2003 - Additional payment for specific types of farming and quality production - Discretion granted to the Member States - Discrimination - Articles 32 EC and 34 EC)

2013/C 344/13

Language of the case: Greek

Referring court

Referring court

Symvoulio tis Epikrateias

Parties to the main proceedings

Parties to the main proceedings

Applicant: Panellinios Sindesmos Viomikhanion Metapiisis Kapnou

Applicant:

Defendants: Ipourgos Ikonomias kai Ikonomikon, Ipourgos Agrotikis Anaptixis kai Trofimon,

Defendants:

Re:

Re:

Request for a preliminary ruling — Symvoulio tis Epikratias — Interpretation of Council Regulation (EC) No 1782/2003 of 29 September 2003 establishing common rules for direct support schemes under the common agricultural policy and establishing certain support schemes for farmers and amending Regulations (EEC) No 2019/93, (EC) No 1452/2001, (EC) No 1453/2001, (EC) No 1454/2001, (EC) No 1868/94, (EC) No 1251/1999, (EC) No 1254/1999, (EC) No 1673/2000, (EEC) No 2358/71 and (EC) No 2529/2001 (OJ 2003 L 270, p. 1) — Interpretation of Articles 2, 32 and 34 EC — Additional payment for specific types of farming — Possibility given to the Member States to determine different proportions of the component of the national ceilings for the purposes of making the additional payment — Differences in treatment of producers of the same products according to the use made of that power by each Member State

Operative part of the judgment

Operative part of the judgment

The examination of the question referred for a preliminary ruling has disclosed nothing capable of affecting the validity of Article 69 of Council Regulation (EC) No 1782/2003 of 29 September 2003 establishing common rules for direct support schemes under the common agricultural policy and establishing certain support schemes for farmers and amending Regulations (EEC) No 2019/93, (EC) No 1452/2001, (EC) No 1453/2001, (EC) No 1454/2001, (EC) No 1868/94, (EC) No 1251/1999, (EC) No 1254/1999, (EC) No 1673/2000, (EEC) No 2358/71 and (EC) No 2529/2001.

---

(1)  OJ C 269, 10.9.2011.

1

---
#### § 1311.13 May TVA waive any provision of these regulations?

In an emergency, TVA may waive any provision of these regulations.
### §689b. Establishment

In accordance with this part, the Administrator shall establish a New Markets Venture Capital Program, under which the Administrator may—

(1) enter into participation agreements with companies granted final approval under section 689c(e) of this title for the purposes set forth in section 689a of this title;

(2) guarantee the debentures issued by New Markets Venture Capital companies as provided in section 689d of this title; and

(3) make grants to New Markets Venture Capital companies, and to other entities, under section 689g of this title.

(Pub. L. 85–699, title III, §353, as added Pub. L. 106–554, §1(a)(8) [§1(b)(3)], Dec. 21, 2000, 114 Stat. 2763, 2763A–655.)
II 

116TH CONGRESS 

1ST SESSION S. 564 

To establish a task force to identify countervailable subsidies and dumping. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 26, 2019 

Mr. PETERS (for himself and Mr. BURR) introduced the following bill; which 

was read twice and referred to the Committee on Finance 

A BILL 

To establish a task force to identify countervailable subsidies 

and dumping. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Self-Initiation Trade 

5 Enforcement Act of 2019’’. 

6 SEC. 2. TASK FORCE TO IDENTIFY COUNTERVAILABLE SUB7 SIDIES AND DUMPING. 

8 (a) IN GENERAL.—Subtitle D of title VII of the Tar9 iff Act of 1930 (19 U.S.C. 1677 et seq.) is amended by 

10 adding at the end the following: 


kjohnson on DSK79L0C42 with BILLS
2 

•S 564 IS

1 ‘‘SEC. 784. TASK FORCE TO IDENTIFY COUNTERVAILABLE 

2 SUBSIDIES AND DUMPING. 

3 ‘‘(a) IN GENERAL.—There is established, in the 

4 International Trade Administration, a task force to be re5 sponsible for— 

6 ‘‘(1) identifying countervailable subsidies and 

7 dumping that are causing material injury or threat8 en to cause material injury to a domestic industry; 

9 ‘‘(2) making recommendations to the Under 

10 Secretary of Commerce for International Trade with 

11 respect to initiating investigations under sections 

12 702(a) and 732(a); and 

13 ‘‘(3) conducting research relating to carrying 

14 out paragraphs (1) and (2). 

15 ‘‘(b) DUTIES.—In carrying out the responsibilities of 

16 the task force under subsection (a), the task force shall— 

17 ‘‘(1) monitor trade flows, government data, 

18 price fluctuations, domestic industry and market 

19 conditions, and all relevant available business infor20 mation to identify potential cases of countervailable 

21 subsidies and dumping that are causing material in22 jury or threaten to cause material injury to a domes23 tic industry; 

24 ‘‘(2) conduct background research on foreign 

25 pricing practices and foreign government subsidies, 

26 including duty evasion and circumvention; and 


kjohnson on DSK79L0C42 with BILLS
3 

•S 564 IS

1 ‘‘(3) prioritize cases that affect small- and me2 dium-sized businesses in the United States. 

3 ‘‘(c) CONSULTATIONS.—In carrying out the respon4 sibilities of the task force under subsection (a), the task 

5 force shall consult with industries in the United States 

6 with respect to countervailable subsidies and dumping.’’. 

7 (b) CLERICAL AMENDMENT.—The table of contents 

8 for title VII of the Tariff Act of 1930 is amended by in9 serting after the item relating to section 783 the following: 

‘‘Sec. 784. Task force to identify countervailable subsidies and dumping.’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
§ 424.23 Prohibited uses. ( a ) *Substances that conceal damage or inferiority or make products appear better or of greater value.* No substance may be used in or on any meat if it conceals damage or inferiority or makes the product appear to be better or of greater value than it is. Therefore: ( 1 ) Paprika or oleoresin paprika may not be used in or on fresh meat, such as steaks, or comminuted fresh meat, such as chopped and formed steaks or patties; or in any other meat consisting of fresh meat (with or without seasoning).
( 2 ) Paprika or oleoresin paprika may be used in or on chorizo sausage and other meat in which paprika or oleoresin paprika is permitted as an ingredient in a standard of identity or composition in part 319 of this subchapter.
( 3 ) Sorbic acid, calcium sorbate, sodium sorbate, and other salts of sorbic acid shall not be used in cooked sausages or any other meat; sulfurous acid and salts of sulfurous acid shall not be used in or on any meat; and niacin or nicotinamide shall not be used in or on fresh meat product; except that potassium sorbate, propylparaben (propyl p-hydroxybenzoate), and calcium propionate, may be used in or on any product, only as provided in 9 CFR Chapter III.
( b ) *Nitrates.* Nitrates shall not be used in curing bacon.
[64 FR 72175, Dec. 23, 1999, as amended at 78 FR 14640, Mar. 7, 2013]
TRIBAL CONSULTATIONS

USDA Seeks Feedback on Ways to Provide Better Access to Grants to Improve 

Water Infrastructure on Tribal Lands and in Colonias

WASHINGTON, Oct. 26, 2021 – U.S. Department of Agriculture (USDA) Under Secretary for Rural 

Development Xochitl Torres Small today announced that USDA is hosting virtual Tribal consultations on Nov. 

30 and Dec. 1 for elected leaders of federally recognized Tribes or their proxies. 

USDA is seeking recommendations on how to improve the Water and Waste Disposal Grants to Alleviate 

Health Risks on Tribal Lands and Colonias program. This program helps people who live in low-income 

communities and federally recognized Tribes access safe and reliable drinking water, waste disposal facilities 

and waste disposal services.

The Department is seeking input from Tribal leaders on:

• Adjusting the program’s scoring criteria to address health risks experienced by federally-recognized 

Tribes due to a lack of access to safe drinking water and wastewater disposal services and facilities.

• Improving program delivery based on the experiences of federally-recognized Tribes who have applied

for and used these grants.

USDA is hosting two consultations. Both sessions will cover the same topics.

• The first consultation will be held virtually on Tuesday, Nov. 30, 2021, at 1:00 p.m. Eastern Time. To 

register, visit https://www.zoomgov.com/meeting/register/vJItdeqgrzwiH_Y6gbZ0-9Qq_eLJmGnniks. 

• The second consultation will be held virtually on Wednesday, Dec. 1, 2021, at 1:00 p.m. Eastern Time. 

To register, visit https://www.zoomgov.com/meeting/register/vJItcGoqzwvHKltKpJ8A4zvQpvrjX6tVRw. 

USDA will issue additional information in the coming days to help Tribal leaders and their proxies prepare for 

the consultations.

If you'd like to subscribe to USDA Rural Development updates, visit our GovDelivery subscriber page.

###

USDA is an equal opportunity provider, employer and lender.
Editorial Note on Part 113
Editorial Note: Nomenclature changes to part 113 appear at 79 FR 55969, Sept. 18, 2014.

§ 113.301 Ovine Ecthyma Vaccine. Ovine Ecthyma Vaccine shall be prepared from tissue culture fluids or virus-bearing tissues obtained from sheep that have developed ovine ecthyma following inoculation with virulent ovine ecthyma virus. Ovine Ecthyma Vaccine is exempt from the requirements prescribed in §§ 113.27 and 113.300(a), (b), and (c). Each serial shall meet the moisture requirements in § 113.300(e) and the special requirements prescribed in this section. Any serial found unsatisfactory by a prescribed test shall not be released. ( a ) *Safety tests.* ( 1 ) Bulk or final container samples of completed product from each serial shall be tested for safety as prescribed in § 113.38.
( 2 ) The prechallenge period of the potency test shall constitute a safety test. If unfavorable reactions attributable to the vaccine occur in either of the vaccinates during the observation period, the serial is unsatisfactory.
( b ) *Potency test.* Final container samples of completed product from each serial and each subserial shall be tested for potency using susceptible lambs. The vaccine shall be prepared as recommended for use on the label. ( 1 ) Each of two lambs (vaccinates) shall be vaccinated by application of the vaccine to a scarified area on the medial surface of the thigh and observed each day for 14 days.
( 2 ) The immunity of the two vaccinates and one or more unvaccinated lambs (controls) shall be challenged in the same manner as for vaccination, using the opposite thigh.
( 3 ) If typical signs of ovine ecthyma, such as hyperemia, vesicles, and pustules do not develop on the controls during the first 2 weeks following challenge and persist for approximately 30 days, the test is a No Test and may be repeated.
( 4 ) If the vaccinates do not show a typical immune reaction, the serial is unsatisfactory: *Provided,* That, an initial active reaction with hyperemia which resolves progressively and disappears within 2 weeks, may be characterized as a typical immune reaction.
[39 FR 27430, July 29, 1974. Redesignated at 55 FR 35562, Aug. 31, 1990, as amended at 56 FR 66786, Dec. 26, 1991]
§ 78.14 Rodeo cattle. ( a ) Rodeo cattle that are test-eligible and that are from a herd not known to be affected may be moved interstate if: ( 1 ) They are classified as brucellosis negative based upon an official test conducted less than 365 days before the date of interstate movement: *Provided, however,* *That:* The official test is not required for rodeo cattle that are moved only between Class Free States;
( 2 ) The cattle are identified with an official eartag or any other official identification device or method approved by the Administrator in accordance with § 78.5;
( 3 ) There is no change of ownership since the date of the last official test;
( 4 ) An ICVI accompanies each interstate movement of the cattle; and
( 5 ) A permit for entry is issued for each interstate movement of the cattle.
( b ) Cattle that would qualify as rodeo cattle, but that are used for breeding purposes during the 365 days following the date of being tested, may be moved interstate only if they meet the requirements for cattle in this subpart and in 9 CFR part 86.
(Approved by the Office of Management and Budget under control number 0579-0047) [78 FR 2070, Jan. 9, 2013]
[date]

Dear friend:

[Name of or Reference to Disaster] caused many challenges and problems for many people.  Our crisis counseling project, [Name of Project], tries to help people cope with the stress of recovery.  To do our jobs well, we need to know more about how people are doing now and if our crisis counselors are finding the best ways to be helpful. 

Inside this packet is a very brief survey.  It will take you only a few minutes to fill out, but it will be very helpful to us.  Your answers will help us to help others. 

The packet has a pen in it for you to use and keep.  It also has a stamped envelope for you to mail in your survey after you are done.  The survey does not ask for your name and is completely anonymous.  No one will know which survey you filled in.  Your answers will be used together with the answers of other people who are also kind enough to help us this week.

Please send your survey in by [date].  Of course, it is fine if you choose not to participate.  Also, you should feel free to leave any question blank that you don’t want to answer. 

Your opinions are important to us.  Thank you for taking the time to complete this survey.

Sincerely,

[Name of Project Director]

[Name of Project]
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                  6-MOS
<FISCAL-YEAR-END>                          JAN-02-1999
<PERIOD-END>                               JUN-20-1998
<CASH>                                           5,813
<SECURITIES>                                         0
<RECEIVABLES>                                    8,665
<ALLOWANCES>                                     1,108
<INVENTORY>                                     45,371
<CURRENT-ASSETS>                                61,963
<PP&E>                                          85,249
<DEPRECIATION>                                  15,702
<TOTAL-ASSETS>                                 157,293
<CURRENT-LIABILITIES>                           37,231
<BONDS>                                         60,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            48
<OTHER-SE>                                      37,226
<TOTAL-LIABILITY-AND-EQUITY>                   157,293
<SALES>                                        244,912
<TOTAL-REVENUES>                               244,912
<CGS>                                          186,068
<TOTAL-COSTS>                                  186,068
<OTHER-EXPENSES>                                59,264
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,799
<INCOME-PRETAX>                                (4,219)
<INCOME-TAX>                                       950
<INCOME-CONTINUING>                            (5,169)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,169)
<EPS-PRIMARY>                                   (1.07)
<EPS-DILUTED>                                   (1.07)
        


</TABLE>